Sphingolipid Activator Proteins
- 15 January 2002
- book chapter
- Published by Wiley
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Biochemical consequences of mutations causing the GM2 gangliosidosesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteinsChemistry and Physics of Lipids, 1999
- Structural and membrane‐binding properties of saposin DEuropean Journal of Biochemistry, 1999
- Interaction of the GM2‐activator protein with phospholipid–ganglioside bilayer membranes and with monolayers at the air–water interfaceEuropean Journal of Biochemistry, 1999
- An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activityEuropean Journal of Human Genetics, 1999
- Topology of glycosphingolipid degradationTrends in Cell Biology, 1996
- Lysosomal storage diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Acid sphingomyelinase possesses a domain homologous to its activator proteins: Saposins B and DProtein Science, 1994
- Molecular Basis of Genetic Sphingolipid Activator Protein Deficiencies.Trends in Glycoscience and Glycotechnology, 1994
- Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher diseaseFEBS Letters, 1991